Showing results (1-10 of 318) with videos related to
Sort By:
Pageof 32
Critical Reviews in Oncology/Hematology|June 4, 2021
TMB or not TMB as a biomarker: That is the questionAlfredo Addeo, Alex Friedlaender, Giuseppe L Banna, et al.Cancer Treatment Reviews|February 17, 2020
KRAS as a druggable target in NSCLC: Rising like a phoenix after decades of development failuresAlex Friedlaender, Alexander Drilon, Glen J Weiss, et al.JAMA Network Open|May 11, 2019
Association of Industry and Academic Sponsorship With Negative Phase 3 Oncology Trials and Reported Outcomes on Participant Survival: A Pooled AnalysisAlfredo Addeo, Glen J Weiss, Bishal GyawaliAnticancer Research|June 1, 2018
Oral Metronomic Vinorelbine in Advanced Non-small Cell Lung Cancer Patients Unfit for ChemotherapyGiuseppe L Banna, Andrea Camerini, Giuseppe Bronte, et al.European Radiology|September 8, 2025
Prediction of oncogene mutation status in non-small cell lung cancer: a systematic review and meta-analysis with a special focus on artificial intelligence-based methodsAlmudena Fuster-Matanzo, Alfonso Picó-Peris, Fuensanta Bellvís-Bataller, et al.Cancer|June 21, 2022
Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trialAlessio Cortellini, Biagio Ricciuti, Hossein Borghaei, et al.Revue Medicale Suisse|May 19, 2021
[Non-small cell lung cancer: a target biology]Nathalie Baudoux, Alfredo AddeoDrugs in Context|July 20, 2018
First-line alectinib for ALK-positive lung cancer: is there room for further improvement?Alfredo Addeo, Giulio MetroCase Reports in Oncology|December 7, 2016
Intrathecal Methotrexate and Craniospinal Radiotherapy Can Be an Effective Treatment of Carcinomatous Meningitis in Patients with Breast Cancer: Case ReportsMagdalena Meissner, Alfredo AddeoPraxis|March 1, 2023
Immunotherapy in Non-Small-Cell Lung Cancer (NSCLC)Geoffrey Merle, Alfredo AddeoPageof 32